1. A clinical study of pyratrione, a tyrosine hydroxylase inhibitor, has been carried out in essential hypertension.
2. Out of thirty-nine patients who received pyratrione, twenty-eight showed a significant decrease in blood pressure.
This content is only available as a PDF.
© 1974 The Biochemical Society and the Medical Research Society